Stocksigma LogoStocksigma Logo

Aurobindo Pharma Subsidiary Apitoria Completes A1 Biochem Acquisition to Strengthen CRDMO Business

Aurobindo Pharma announced that its wholly owned subsidiary, Apitoria Pharma, completed the acquisition of A1 Biochem Group's contract research services

Aurobindo Pharma Subsidiary Apitoria Completes A1 Biochem Acquisition to Strengthen CRDMO Business

Aurobindo Pharma Ltd 路 Others (Uncategorized) 路 03 Oct 2026, 12:05 am

Aurobindo Pharma Subsidiary Apitoria Completes A1 Biochem Acquisition to Strengthen CRDMO Business Aurobindo Pharma announced that its wholly owned subsidiary, Apitoria Pharma, completed the acquisition of A1 Biochem Group's contract research services business on 2nd Oct'26. Apitoria now holds an 80% stake in A1 Biochem Labs (India), while former promoter Dr. Rajendra Gadikota retains 20%. Concurrently, A1 Labs India acquired 100% of US-based A1 Biochem Labs LLC. The transaction provides Apitoria access to an established CRO platform with 50+ clients and 800+ completed projects, advancing its transition into an integrated CRDMO platform across India and the US.

Original exchange filing (PDF)

More announcements from Aurobindo Pharma Ltd

All Aurobindo Pharma Ltd announcements